CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 223 entries

View as:

Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT01078155 Org: User:

Start: 03/31/09 End: 05/31/14 Due: 05/31/15

A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01617928 Org: User:

Start: 05/31/12 End: 07/31/13 Due: 07/31/14

Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice

Phase: N/A Priority: Normal

NCT ID: NCT01078090 Org: User:

Start: 04/30/03 End: 03/31/13 Due: 03/31/14

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal

NCT ID: NCT01306617 Org: User:

Start: 02/28/11 End: 10/31/12 Due: 10/31/13

Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan

Phase: N/A Priority: Normal

NCT ID: NCT01424319 Org: User:

Start: 08/31/11 End: 07/31/12 Due: 07/31/13

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Phase: N/A Priority: Normal

NCT ID: NCT01466062 Org: User:

Start: 08/31/11 End: 04/30/12 Due: 04/30/13

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Phase: N/A Priority: Normal

NCT ID: NCT01758705 Org: User:

Start: 02/28/13 End: 03/31/16 Due: 03/31/17

ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01110486 Org: User:

Start: 03/31/10 End: 09/30/13 Due: 09/30/14

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal

NCT ID: NCT00517920 Org: User:

Start: 09/30/07 End: 06/30/12 Due: 06/30/13

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

Phase: N/A Priority: Normal

NCT ID: NCT01767116 Org: User:

Start: 12/31/12 End: 08/31/14 Due: 08/31/15

A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study

Phase: N/A Priority: Normal

NCT ID: NCT01609933 Org: User:

Start: 12/18/12 End: 05/03/17 Due: 05/03/18

Kaletra in Combination With Antiretroviral Agents

Phase: N/A Priority: Normal

NCT ID: NCT01076179 Org: User:

Start: 09/30/08 End: 01/31/16 Due: 01/31/17

A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01736176 Org: User:

Start: 03/31/13 End: 12/31/15 Due: 12/31/16

Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00645177 Org: User:

Start: 07/31/08 End: 12/31/09 Due: 12/31/10

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Phase: N/A Priority: Normal

NCT ID: NCT01159743 Org: User:

Start: 07/31/10 End: 09/30/11 Due: 09/30/12

A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study

Phase: N/A Priority: Normal

NCT ID: NCT01747655 Org: User:

Start: 02/28/13 End: 07/31/15 Due: 07/31/16

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01339650 Org: User:

Start: 05/06/11 End: 11/30/17 Due: 11/30/18

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Phase: N/A Priority: Normal

NCT ID: NCT00445198 Org: User:

Start: 04/30/07 End: 12/31/10 Due: 12/31/11

A Study to Evaluate Chronic Hepatitis C Infection

Phase: N/A Priority: Normal

NCT ID: NCT01716585 Org: User:

Start: 11/30/12 End: 10/31/14 Due: 10/31/15

Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01314261 Org: User:

Start: 03/31/11 End: 02/28/13 Due: 02/28/14

Hydrocodone/Acetaminophen for Acute Pain Following Bunionectomy

Phase: N/A Priority: Normal

NCT ID: NCT01038609 Org: User:

Start: 12/31/09 End: 05/31/10 Due: 05/31/11

Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)

Phase: N/A Priority: Normal

NCT ID: NCT00635193 Org: User:

Start: 07/31/07 End: 10/31/09 Due: 10/31/10

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

Phase: N/A Priority: Normal

NCT ID: NCT01441635 Org: User:

Start: 09/08/11 End: 05/17/14 Due: 05/17/15

Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease

Phase: N/A Priority: Normal

NCT ID: NCT01018875 Org: User:

Start: 12/31/09 End: 02/28/11 Due: 02/28/12

Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab

Phase: N/A Priority: Normal

NCT ID: NCT01077128 Org: User:

Start: 09/30/09 End: 09/30/12 Due: 09/30/13

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis	NCT01078155	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-03-31	2014-05-31	2015-05-31	-	-	2025-07-14
A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors	NCT01617928	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-05-31	2013-07-31	2014-07-31	-	-	2025-07-14
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice	NCT01078090	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2003-04-30	2013-03-31	2014-03-31	-	-	2025-07-14
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-Naïve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection	NCT01306617	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-02-28	2012-10-31	2013-10-31	-	-	2025-07-14
Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan	NCT01424319	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-08-31	2012-07-31	2013-07-31	-	-	2025-07-14
Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions	NCT01466062	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-08-31	2012-04-30	2013-04-30	-	-	2025-07-14
Post Marketing Observational Study on Venezuelan Patients With Psoriasis	NCT01758705	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2013-02-28	2016-03-31	2017-03-31	-	-	2025-07-14
ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors	NCT01110486	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-03-31	2013-09-30	2014-09-30	-	-	2025-07-14
Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)	NCT00517920	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-09-30	2012-06-30	2013-06-30	-	-	2025-07-14
A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection	NCT01767116	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-12-31	2014-08-31	2015-08-31	-	-	2025-07-14
A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination Study	NCT01609933	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-12-18	2017-05-03	2018-05-03	-	-	2025-07-14
Kaletra in Combination With Antiretroviral Agents	NCT01076179	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-09-30	2016-01-31	2017-01-31	-	-	2025-07-14
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease	NCT01736176	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2013-03-31	2015-12-31	2016-12-31	-	-	2025-07-14
Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer	NCT00645177	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2008-07-31	2009-12-31	2010-12-31	-	-	2025-07-14
A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine	NCT01159743	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2010-07-31	2011-09-30	2012-09-30	-	-	2025-07-14
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study	NCT01747655	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2013-02-28	2015-07-31	2016-07-31	-	-	2025-07-14
Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	NCT01339650	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-05-06	2017-11-30	2018-11-30	-	-	2025-07-14
A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies	NCT00445198	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-04-30	2010-12-31	2011-12-31	-	-	2025-07-14
A Study to Evaluate Chronic Hepatitis C Infection	NCT01716585	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2012-11-30	2014-10-31	2015-10-31	-	-	2025-07-14
Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected Subjects	NCT01314261	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-03-31	2013-02-28	2014-02-28	-	-	2025-07-14
Hydrocodone/Acetaminophen for Acute Pain Following Bunionectomy	NCT01038609	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-12-31	2010-05-31	2011-05-31	-	-	2025-07-14
Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)	NCT00635193	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2007-07-31	2009-10-31	2010-10-31	-	-	2025-07-14
Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids	NCT01441635	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2011-09-08	2014-05-17	2015-05-17	-	-	2025-07-14
Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease	NCT01018875	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-12-31	2011-02-28	2012-02-28	-	-	2025-07-14
Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab	NCT01077128	AbbVie (prior sponsor, Abbott)	user2@example.com	None	2009-09-30	2012-09-30	2013-09-30	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance